503 filings
Page 5 of 26
UPLOAD
5iscjjvqabrtu5iaw6
29 Dec 22
Letter from SEC
12:00am
UPLOAD
q0xv5uw owu
21 Dec 22
Letter from SEC
12:00am
CORRESP
j2he0eo9bujwa4m36
21 Dec 22
Correspondence with SEC
12:00am
CORRESP
nh9ohdq9jm x0ak5iz
16 Dec 22
Correspondence with SEC
12:00am
UPLOAD
zuoicu pt
15 Dec 22
Letter from SEC
12:00am
8-K
fokurq
13 Dec 22
OpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection Panel
4:28pm
8-K
gli8ic5nxjqteax
30 Nov 22
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
o7eua6ps htdwq2l4
10 Nov 22
OpGen Reports Third Quarter 2022 Financial Results and Provides Business Update
4:19pm
DEFA14A
0lfe1223o4
17 Oct 22
Additional proxy soliciting materials
4:20pm
D
yqybm6bzhzb om
11 Oct 22
$3.38 mm in equity / options, sold $3.38 mm, 1 investor
9:02pm
8-K
gfeu i6t2u0e9xd1z7ql
3 Oct 22
OpGen Announces $3.38 Million Registered Direct Offering
5:16pm
424B5
vmpeizlz h9te4
3 Oct 22
Prospectus supplement for primary offering
11:19am
424B5
6el qahndbx8
30 Sep 22
Prospectus supplement for primary offering
4:16pm
424B5
2ecfan0j
30 Sep 22
Prospectus supplement for primary offering
4:14pm
424B5
dhscl36mvam5n7xr jx
30 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
5od0vhdov jxuxxtopu8
30 Sep 22
Prospectus supplement for primary offering
11:21am